Paracetamol Baxter

Paracetamol, the active ingredient in Paracetamol Baxter, is an analgesic presented as an injectable solution for intravenous use. It reduces pain and fever in patients as directed by a prescriber.

GNH USA supplies Paracetamol Baxter as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals worldwide.

Paracetamol Baxter is used to manage pain and fever by acting on central prostaglandin pathways.

Pain: provides analgesia for mild to moderate pain such as headache or musculoskeletal discomfort. Fever: lowers elevated body temperature in febrile conditions. Post‑operative pain: assists in controlling pain after surgical procedures.

Paracetamol administered intravenously may be associated with several adverse reactions.

Common Side Effects: - Nausea or vomiting - Mild skin rash or itching - Transient hypotension during infusion - Injection site discomfort or erythema - Elevated liver enzymes without clinical symptoms

Serious or Rare Side Effects: - Acute liver failure, especially with overdose or pre‑existing hepatic disease - Anaphylactic or severe allergic reactions - Stevens‑Johnson syndrome or toxic epidermal necrolysis - Hematologic abnormalities such as thrombocytopenia - Severe renal impairment in susceptible patients

When using Paracetamol Baxter, clinicians should observe the following precautions.

Liver function monitoring: assess hepatic enzymes before and during therapy. Avoid in severe hepatic impairment: contraindicated in patients with established liver failure. Use caution in renal impairment: adjust therapy in patients with reduced kidney function. Avoid concomitant hepatotoxic drugs: limit use with other agents that may stress the liver. Pregnancy and breastfeeding: safety data are limited; evaluate risk‑benefit ratio. Store at ambient temperature: keep in original packaging, protect from moisture and direct sunlight.

Paracetamol Baxter can interact with several medications; awareness of interaction severity is essential.

Major Interactions (Avoid): - Warfarin: may increase anticoagulant effect and bleeding risk. - Other hepatotoxic agents (e.g., isoniazid, high‑dose acetylcysteine): risk of liver injury. - Chronic alcohol use: potentiates hepatic toxicity.

Moderate Interactions (Monitor Closely): - Carbamazepine or phenytoin: enzyme induction may reduce paracetamol efficacy. - Oral contraceptives: may slightly lower plasma concentrations of contraceptive hormones. - Rifampicin: may increase metabolism leading to reduced analgesic effect.